Emergency Live – Pre-Hospital Care, Ambulance Services, Fire Safety and Civil Protection Magazine
It is therefore a relevant social problem, so much so that the World Health Organization has included it in the priority list of preventable diseases, giving specific guidelines for its screening.
In fact, the importance of screening is very high: it is estimated that diabetic patients who do not undergo regular screening have a 4-fold increased risk of developing severe retinopathy.
As the name implies, the cause of diabetic retinopathy is diabetes, a condition that affects more than 415 million worldwide, a number estimated to rise to 642 million by 2040.
There are 2 forms of diabetes:
In each case, it is a chronic and slowly progressive disease that induces complications in several target organs:
The main risk factors for the development and progression of diabetic retinopathy are:
Among these risk factors, glycemic compensation is the most important: maintaining good glycemic control (glycated hemoglobin less than 7) in fact reduces the risk of development and progression of diabetic retinopathy.
In terms of the mechanism of action, diabetic retinopathy is a neurovascular disease: it affects the neuronal and endothelial cells of the retina.
Damage to these cells leads to:
Progressive ischemia leads to the formation of neovases, which can bleed causing intraocular hemorrhage (called hemovitreo), resulting in acute vision loss.
Sometimes this event resolves with spontaneous reabsorption of the blood; other times surgical removal of the vitreal hemorrhage by vitrectomy is necessary.
Over time, untreated neovases become fibrotic and can lead to retinal detachment, a serious complication that results in abrupt visual decline and requires complex emergency surgery, often followed by failure to recover or partial recovery of vision.
These vessels can also grow on the surface of the iris (the colored part of the eye) and lead to pictures of iris rubeosis (presence of capillaries on the iris) and so-called neovascular glaucoma, a form of glaucoma characterized by a major increase in intraocular pressure with irreversible damage to the optic nerve followed by blindness and pain.
This is a complication that is unlikely to be cured by medical and surgical therapies.
It becomes symptomatic only when the pathology reaches the region of the macula, or when the severe complications that follow ischemia and the proliferating phase of the disease occur so at an already advanced stage.
This is also why a careful and early screening program is essential.
We have many weapons to make early diagnosis of diabetic retinopathy and to monitor it as best we can.
Screening, in particular, is based on ocular fundus analysis.
The first evaluation should be performed:
The interval between follow-up visits is decided by the specialist based on the presence or absence of diabetic retinopathy and its severity.
The diagnostics of retinal diseases, including that of diabetic retinopathy, has greatly advanced in recent years: today there are instruments that allow in a single visit an accurate assessment of all aspects of this disease.
The diagnostic pathway involves the performance of:
Each of these examinations gives us a piece of the ‘puzzle’ for proper final evaluation.
OCT, on the other hand, is the exam that allows us to assess increased macular thickness due to fluid accumulation (macular edema), as well as the presence of tractional epiretinal membranes (‘nonelastic,’ fibrotic tissue that is able to exert traction on the macula leading to edema formation or puncturing it in the center with severe damage on central vision) on the retina that may require surgical intervention.
Finally, autofluorescence allows the study of macular edema, while angio-OCT studies macular ischemia, edema, and shows changes even in the subclinical phase, that is, before symptoms occur.
These examinations also make it possible to check the response to possible therapies and monitor the progress of the disease.
The first step of therapy is careful monitoring of the underlying pathology, namely diabetes, motivating and informing the patient about the importance of maintaining good blood glucose levels.
The second step is a good preventive campaign that in the overall evaluation of the diabetic patient makes use of fundus examination and new generation imaging with macula study (OCT, angio- OCT and FAF).
When the disease has caused visual decline because it has affected the macula (macular edema), we have the less invasive but effective techniques of ‘grid’ or direct laser photocoagulation used for a long time in treating the edema itself:
Help in the early stages of macular edema is provided by supplements containing turmeric and similar substances.
These new therapies often allow the recovery of decent central vision with improvement in the quality of life of our patients.
When the disease affects the mid-peripheral part of the retina with ischemia and neovases, the treatment of choice is sector laser photocoagulation (for localized ischemia in one area of the retina) or panretinal (affecting all sectors when the damage is more extensive).
This treatment aims to slow down the disease and prevent the onset of serious complications.
Raising awareness among diabetic patients is very important because we need their help first and foremost to achieve the best results.
Emergency Live Even More…Live: Download The New Free App Of Your Newspaper For IOS And Android
Diabetic Retinopathy: Prevention And Controls To Avoid Complications
Diagnosis Of Diabetes: Why It Often Arrives Late
Diabetic Microangiopathy: What It Is And How To Treat It
Diabetes: Doing Sport Helps Blood Glucose Control
Type 2 Diabetes: New Drugs For A Personalised Treatment Approach
The Diabetic Diet: 3 False Myths To Dispel
Paediatrics, Diabetic Ketoacidosis: A Recent PECARN Study Sheds New Light On The Condition
Orthopaedics: What Is Hammer Toe?
Hollow Foot: What It Is And How To Recognise It
Occupational (And Non-Occupational) Diseases: Shock Waves For The Treatment Of Plantar Fasciitis
Flat Feet In Children: How To Recognise Them And What To Do About It
Swollen Feet, A Trivial Symptom? No, And Here’s What Serious Diseases They May Be Associated With
Varicose Veins: What Are Elastic Compression Stockings For?
Diabetes Mellitus: Symptoms, Causes And Significance Of The Diabetic Foot
Diabetic Foot: Symptoms, Treatment And Prevention
Type 1 And Type 2 Diabetes: What Are The Differences?
Diabetes And Cardiovascular Risk: What Are The Main Complications
Diabetes: Causes, Symptoms And Complications
GSD
Prev Post
Mediterranean anemia: causes, symptoms and treatment
Next Post
Pediatric patient: what is arthrogryposis?
Arteriosclerosis: what is it?
Psoriatic arthritis: how to recognize it?
Supraventricular tachycardia: definition, diagnosis, treatment, and prognosis
Skin diseases: xeroderma pigmentosum
Latest articles
Ukraine, Italian Red Cross efforts for Christmas: new mission with ambulances…
Ukraine: ICRC president meets authorities, families of prisoners of war, and…
The ANPAS (and Italy) to come: interview with the new President Niccolò Mancini
International Volunteer Day 2022, IFRC: “Believe in the power of kindness”
December 5, World Volunteer Day: the 2022 theme is ‘Solidarity through…
Marketplace
Coulson Aviation Secures C-130H Hercules Airtanker Four-Year Firefighting…
HEMS, Swiss Air-Rescue (Rega) orders 12 new H145 pentapalas for its mountain…
Focaccia Group: first ambulance of a fleet delivered to Sanitaservice
Fotokite Sigma at IEDO 2022: Transport Case and Rooftop Box
HIKMICRO thermography: ensure your safety, find potential risks
Emergency Live is the only multilingual magazine dedicated to people involved in rescue and emergency. As such, it is the ideal medium in terms of speed and cost for trading companies to reach large numbers of target users; for example, all companies involved in some way in the equipping of specialised means of transport. From vehicle manufacturers to companies involved in equipping those vehicles, to any supplier of life- saving and rescue equipment and aids.
Emergency Live
Piazzale Badalocchio 9/b, 43126 Parma (PR) – Italy
Phone: +39 340 2246247
VAT Number: IT02277610347
Write us: go to the form mail
This website is not intended for the purpose of providing medical advice. All information, content, and material is for information and educational purposes and are not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
All the contents inside this website are addressed to EMS, Rescue and Medical professionals. All the information in the following pages are focused on the health sector, medical devices, pharmaceutical products or products inside these categories, and they request the use of a professional of the health sector.